Transcriptomics

Dataset Information

0

Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of treatment failure independent of intratumor heterogeneity

ABSTRACT: Emerging biomarkers based on medical images and molecular characterization of tumor biopsies open up for combining the two disciplines and exploiting their synergy in treatment planning. We compared pretreatment classification of cervical cancer patients by two previously validated imaging- and gene-based hypoxia biomarkers, evaluated the influence of intratumor heterogeneity, and investigated the benefit of combining them in prediction of treatment failure. The imaging-based biomarker was hypoxic fraction, determined from diagnostic dynamic contrast enhanced (DCE)-MR images. The gene-based biomarker was a hypoxia gene expression signature determined from tumor biopsies. Paired data were available for 118 patients. Intratumor heterogeneity was assessed by variance analysis of MR images and multiple biopsies from the same tumor. The two biomarkers were combined using a dimension-reduction procedure. The biomarkers classified 75% of the tumors with the same hypoxia status. Both intratumor heterogeneity and distribution pattern of hypoxia from imaging were unrelated to inconsistent classification by the two biomarkers, and the hypoxia status of the slice covering the biopsy region was representative of the whole tumor. Hypoxia by genes was independent on tumor cell fraction and showed minor heterogeneity across multiple biopsies in 9 tumors. This suggested that the two biomarkers could contain complementary biological information. Combination of the biomarkers into a composite score led to improved prediction of treatment failure (HR:7.3) compared to imaging (HR:3.8) and genes (HR:3.0) and prognostic impact in multivariate analysis with clinical variables. In conclusion, combining imaging- and gene-based biomarkers enables more precise and informative assessment of hypoxia-related treatment resistance in cervical cancer, independent of intratumor heterogeneity.

ORGANISM(S): Homo sapiens

PROVIDER: GSE146114 | GEO | 2020/06/26

REPOSITORIES: GEO

Json Xml

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

Genomics Combining imaging- and gene-based hypoxia biomarkers in cervical cancer improves prediction of treatment failure independent of intratumor heterogeneity
| PRJNA609323 | ENA
Proteomics Characterization of spatial heterogeneity in metastasized colorectal cancer by MALDI imaging
2023-02-17 | PXD039409 | Pride
Transcriptomics Survey of Intra- and Inter-Tumour Heterogeneity of Gene Expression in Cervical Cancer
2006-10-01 | GSE5787 | GEO
Transcriptomics Transcription profiling of human cervical cancer patient biopsies to explore intratumour heterogeneity reveals that intratumor variation is low for most probe sets tested but that multiple biopsies are recommended for reliable estimates of gene expression
2007-11-11 | E-GEOD-5787 | biostudies-arrayexpress
Transcriptomics A prognostic hypoxia gene signature with low heterogeneity within the dominant tumour lesion in prostate cancer patients.
2022-04-01 | GSE178631 | GEO
Transcriptomics MR Imaging Distinguishes Tumor Hypoxia Levels of Different Prognostic and Biological Significance in Cervical Cancer
2020-09-01 | GSE147384 | GEO
Transcriptomics Transcriptome profiling of multiregional sampling in hepatocellular carcinoma
2020-01-16 | E-MTAB-5905 | biostudies-arrayexpress
Transcriptomics Single-cell RNA-seq reveals intratumoral heterogeneity in primary uveal melanomas and discloses new targetable vulnerability
2021-01-25 | GSE138433 | GEO
Proteomics Identification of proteomic markers in head and neck cancer using MALDI-MS Imaging, LC-MS/MS and IHC
2018-11-14 | PXD009144 | Pride
Transcriptomics Methylome profiling of glioblastoma biopsies obtained by neuro-navigation in four distinct areas for 10 patients (necrotic zone, tumor zone, interface, and peripheral brain zone).
2016-09-19 | E-MTAB-5109 | biostudies-arrayexpress